Skip to main content
. 2022 Sep 21;64(1):65–70. doi: 10.1002/jmd2.12335

FIGURE 1.

FIGURE 1

Gross motor function measurement at baseline (prior to elamipretide dose) and during elamipretide treatment (Case 2)